Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Zenith share issue

tada

Nov 13, 2017 11:10PM

Re: Zenith share issue

BearDownAZ

Nov 14, 2017 12:34PM

Re: Zenith share issue

BearDownAZ

Nov 14, 2017 12:47PM

Re: Zenith share issue

Nextblockbuster

Nov 14, 2017 01:11PM

Re: Zenith share issue

jbuffett62

Nov 15, 2017 11:07AM

Re: Zenith share issue

Nextblockbuster

Nov 15, 2017 12:39PM

Re: Zenith share issue

fouremm

Nov 15, 2017 02:41PM

Nextblockbuster

Rank: President [?]

Points: 2717 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith share issue

in response to

Re: Zenith share issue

fouremm

posted on Nov 15, 2017 03:30PM

fouremm, $3USD is the minimum for a NASDAQ listing, coincidence?? maybe for a NAsdaq IPO it does not matter as it would be priced higher than $3 anyways . Would like to see an IPO but a CVR or buyout would be preferred for just ZEN 3694 and than IPO the other molecule indications, THE STAR FACTORY AS MENTIONED by SF

6 Recommendations

Reply New Message

Back To Forum List View

Please to post a reply